Refresh

Jagsonpal Pharmaceuticals Ltd. - Research Center

507789 JAGSNPHARM Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

236.71 226.10 187.95 158.57 168.25
Expenses

Material consumed

93.18 95.96 80.80 56.23 72.93

Manufacturing expenses

0.29 0.47 0.52 0.64 1.41

Personnel expenses

56.42 57.68 53.98 50.37 46.61

Selling expenses

15.47 12.09 11.83 16.29 -

Adminstrative expenses

37.21 34.11 21.73 26.49 36.54

Expenses capitalised

- - - - -

Cost of sales

202.56 200.30 168.87 150.04 157.49

Operating profit

34.15 25.79 19.08 8.53 10.76

Other recurring income

5.73 3.34 4.39 2.53 -

Adjusted PBDIT

39.89 29.13 23.47 11.06 -

Financial expenses

0.41 0.29 1.09 0.51 0.75

Depreciation

1.21 1.53 0.51 1.13 1.02

Other write offs

- - - - -

Adjusted PBT

38.27 27.32 21.87 9.41 9.00

Tax charges

8.09 7.73 4.81 1.54 1.79

Adjusted PAT

30.18 19.59 17.06 7.87 7.22

Non recurring items

-5.01 1.36 0.15 - -

Other non cash adjustments

- - - - -

Reported net profit

25.17 20.95 17.21 7.87 7.22

Earnigs before appropriation

94.54 79.53 64.90 49.00 41.92

Equity dividend

- 10.48 2.62 1.31 0.79

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

94.54 69.05 62.28 47.69 41.13
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com